Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.verified

002294.SZ

Price:

$58.7

Market Cap:

$65.44B

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefurox...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2009-09-10

Stock Exchange

SHZ

Ticker

002294.SZ

The Enterprise Value as of December 2025 (TTM) for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is 64.69B

According to Shenzhen Salubris Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 64.69B. This represents a change of 38.13% compared to the average of 46.83B of the last 4 quarters.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Historical Enterprise Value (quarterly & annually)

How has 002294.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Shenzhen Salubris Pharmaceuticals Co., Ltd. over the last ten years is 29.85B. The current 64.69B Enterprise Value has changed 21.57% with respect to the historical average. Over the past ten years (40 quarters), 002294.SZ's Enterprise Value was at its highest in in the September 2025 quarter at 66.53B. The Enterprise Value was at its lowest in in the March 2020 quarter at 18.34B.

Quarterly (TTM)
Annual

Average

29.85B

Median

29.75B

Minimum

19.90B

Maximum

42.19B

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shenzhen Salubris Pharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 45.83%

Maximum Annual Enterprise Value = 42.19B

Minimum Annual Increase = -52.84%

Minimum Annual Enterprise Value = 19.90B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202433.46B-4.74%
202335.12B4.45%
202233.62B29.28%
202126.01B-9.30%
202028.67B43.22%
201920.02B0.62%
201819.90B-52.84%
201742.19B45.83%
201628.93B-5.33%
201530.56B37.38%

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Average Enterprise Value

How has 002294.SZ Enterprise Value performed in the past?

The current Enterprise Value of Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

34.07B

5-year avg

31.37B

10-year avg

29.85B

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Enterprise Value vs. Peers

How is 002294.SZ’s Enterprise Value compared to its peers?

Shenzhen Salubris Pharmaceuticals Co., Ltd.’s Enterprise Value is less than Huadong Medicine Co., Ltd (74.23B), less than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (65.12B), greater than Imeik Technology Development Co.,Ltd. (40.87B), less than Shanghai Pharmaceuticals Holding Co., Ltd (91.51B), greater than Haisco Pharmaceutical Group Co., Ltd. (62.98B), less than Zhejiang NHU Company Ltd. (74.74B), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (57.79B), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (100.20B), greater than Gan & Lee Pharmaceuticals. (37.39B), greater than Hangzhou Tigermed Consulting Co., Ltd. (37.07B),

Build a custom stock screener for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Salubris Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Salubris Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?

What is the 3-year average Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?

What is the 5-year average Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?

How does the current Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) compare to its historical average?